Dr. Veronica Demtchouk, MD

Dr. Demtchouk practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Demtchouk's NPI, 1134548381, was assigned on April 15, 2014. Dr. Demtchouk graduated from Rutgers Robert Wood Johnson Medical School in 2014. Dr. Demtchouk holds Florida license ME152428.

Dr. Demtchouk's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Demtchouk's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demtchouk practices. Vendor and product names are available with a free account.

Gynecology is Dr. Demtchouk's primary specialty in the NPI Registry, under taxonomy code 207VG0400X. Dr. Demtchouk is board certified in female pelvic medicine and reconstructive surgery by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Demtchouk's licenses on file in 2 states: Florida and Rhode Island.

Dmand AI lists bladder disease, hysterectomy, menopause, pelvic prolapse, UTI and vaginal prolapse repair among the conditions Dr. Demtchouk treats.

CMS data shows 163 Medicare services from Dr. Demtchouk across 5 procedure codes in 2024, for 114 Medicare patients. Medicare paid $8,876 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Dr. Demtchouk in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Demtchouk's median patient age at 73, with 100% women.

In 2024, Dr. Demtchouk wrote 363 Medicare Part D claims for 135 patients. 71% of them were for generic drugs. CMS names the drug for 251 of them, across 5 drugs with 11 or more claims each, at $63,876 in total drug cost. In 2023, CMS named 565 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Demtchouk for performance year 2024, reported through an alternative payment model (APM). Dr. Demtchouk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Demtchouk as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Demtchouk, published from 2019 to 2025. The most frequent topics are Patient Satisfaction and Suburethral Slings. Dr. Demtchouk has published most often in Female Pelvic Med Reconstr Surg. Dr. Demtchouk's most frequent co-authors are William D. Winkelman, MD, Liza Gail Brecher, MD and Eman A. Elkadry, MD.

CMS Open Payments shows 37 general payments to Dr. Demtchouk from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. Coloplast Corp paid the most, $593.

Dr. Demtchouk graduated from Rutgers Robert Wood Johnson Medical School in 2014.

Dr. Demtchouk is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.